drugset / Trial / NCT01205581

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

NCT01205581 ↗

Phase 2 Completed 85 enrolled St. Jude Children's Research Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open label-study of Fluzone HD, a high-dose form of trivalent, inactivated influenza vaccine (TIV), vs. Fluzone, a standard-dose form of TIV. Subjects with cancer or HIV will be vaccinated twice with one of the two vaccines and evaluated for development of immune responses.

Timeline

Start
2010-09
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluzone HD Vaccine — —
Comparator Fluzone Standard Dose Vaccine Vaccine — —